Ozempic, a drug commonly prescribed for type 2 diabetes, has also gained attention for its weight loss effects. But while some patients praise it for managing blood sugar and shedding pounds, others ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Lars Fruergaard Jørgensen said he was “surprised” that the Ozempic-maker’s largest shareholder, the Novo Nordisk Foundation, had decided to remove him. “I did not see this coming,” he ...